Search
Trifarotene
go.drugbank.com/drugs/DB12808ApprovedInvestigational[A187081] Trifarotene is considered the first of the "fourth-generation" retinoids due to its uniquely selective activity - this selectivity appears to confer improved efficacy and reduced side effects
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2B6 SubstratesGamithromycin
go.drugbank.com/drugs/DB11416ExperimentalVet approvedGamithromycin is an antibiotic used in cattle.
Imiquimod
go.drugbank.com/drugs/DB00724ApprovedInvestigationalImiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas.
International brands: Li Di, Nan BoCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesLevamlodipine
go.drugbank.com/drugs/DB09237ApprovedInvestigationalLevamlodipine, also known as S-amlodipine, is a pharmacologically active enantiomer of [amlodipine], an antihypertensive medication.
Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesGuselkumab
go.drugbank.com/drugs/DB11834ApprovedInvestigationalIL-23 is an inflammatory cytokine that activates the CD4+ T-helper (Th17) cell pathway to mediate the inflammatory cascade that induces psoriatic plaque formation [A20357].
Nomifensine
go.drugbank.com/drugs/DB04821ApprovedWithdrawnNomifensine, formerly marketed as Merital capsules, was associated with an increased incidence of hemolytic anemia.
Synonyms: D,L-nomifensineSea salt
go.drugbank.com/drugs/DB11266ApprovedUnlike sea salt, table salt usually contains an additive to prevent clumping and involves addition of iodine.
Products: Ruby Cell 4u Mud Moisture PureEmicizumab
go.drugbank.com/drugs/DB13923ApprovedInvestigationalEmicizumab was originated as an improved form of hBS23 and it was approved on November 16, 2017.[A31279, L1016] It was created by Chugai Pharmaceuticals Co.
Clesrovimab
go.drugbank.com/drugs/DB18877ApprovedInvestigationalpatients, nor are vaccines immediately effective in this population, clesrovimab and similar monoclonal antibodies like [nirsevimab] are designed to provide passive immunization against RSV infection as an